Claritev Gross Profit 2019-2025 | CTEV
Claritev gross profit from 2019 to 2025. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
| Claritev Annual Gross Profit (Millions of US $) |
|
|---|---|
| 2024 | $691 |
| 2023 | $726 |
| 2022 | $876 |
| 2021 | $942 |
| 2020 | $619 |
| 2019 | $833 |
| 2018 | $891 |
| Claritev Quarterly Gross Profit (Millions of US $) |
|
|---|---|
| 2025-03-31 | $171 |
| 2024-12-31 | $175 |
| 2024-09-30 | $170 |
| 2024-06-30 | $172 |
| 2024-03-31 | $174 |
| 2023-12-31 | $183 |
| 2023-09-30 | $182 |
| 2023-06-30 | $179 |
| 2023-03-31 | $182 |
| 2022-12-31 | $187 |
| 2022-09-30 | $197 |
| 2022-06-30 | $240 |
| 2022-03-31 | $251 |
| 2021-12-31 | $252 |
| 2021-09-30 | $244 |
| 2021-06-30 | $232 |
| 2021-03-31 | $215 |
| 2020-12-31 | $181 |
| 2020-09-30 | $76 |
| 2020-06-30 | $155 |
| 2020-03-31 | $207 |
| 2019-12-31 | |
| 2018-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.473B | $0.931B |
| Claritev Corporation is a healthcare technology, data and insights company. Claritev Corporation, formerly known as MultiPlan, is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $38.234B | 52.81 |
| Hims & Hers Health (HIMS) | United States | $12.982B | 134.88 |
| Tempus AI (TEM) | United States | $10.012B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.465B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.309B | 67.32 |
| Privia Health (PRVA) | United States | $2.902B | 198.33 |
| Enovis (ENOV) | United States | $1.848B | 10.30 |
| Clover Health Investments (CLOV) | United States | $1.791B | 0.00 |
| Schrodinger (SDGR) | United States | $1.498B | 0.00 |
| Phreesia (PHR) | United States | $1.456B | 0.00 |
| Omnicell (OMCL) | United States | $1.281B | 22.59 |
| Azenta (AZTA) | United States | $1.258B | 58.47 |
| 10x Genomics (TXG) | United States | $1.024B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.618B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.534B | 0.00 |
| Talkspace (TALK) | United States | $0.486B | 145.25 |
| Veradigm (MDRX) | United States | $0.476B | 0.00 |
| Standard BioTools (LAB) | United States | $0.395B | 0.00 |
| TruBridge (TBRG) | United States | $0.363B | 805.00 |
| Nyxoah SA (NYXH) | Belgium | $0.274B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.260B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.195B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.141B | 0.00 |
| Pulmonx (LUNG) | United States | $0.126B | 0.00 |
| American Well (AMWL) | United States | $0.116B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.099B | 0.00 |
| CareCloud (CCLD) | United States | $0.086B | 3.27 |
| 111 (YI) | China | $0.067B | 0.00 |
| Outset Medical (OM) | United States | $0.067B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.056B | 0.00 |
| HeartBeam (BEAT) | United States | $0.053B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.051B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.038B | 0.00 |
| Zhongchao (ZCMD) | China | $0.033B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.017B | 0.00 |
| Precipio (PRPO) | United States | $0.015B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.012B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.009B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.000B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |